Holdings (Monthly)
Guide ↗
Select Biotechnology Portfolio
· Fidelity Select Portfolios| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYSTAL BIOTECH INC | 501147102 | Feb 2026 | 1,802,622 | -3,900 | $557.1M | +11.9% | 10.58% | EC |
| 2 | ABBVIE INC | 00287Y109 | Feb 2026 | 2,230,183 | -819,249 | $485.6M | -31.4% | 9.22% | EC |
| 3 | AMGEN INC | 031162100 | Feb 2026 | 1,020,981 | -128,570 | $343.9M | -22.9% | 6.53% | EC |
| 4 | GILEAD SCIENCES INC | 375558103 | Feb 2026 | 1,886,298 | -1,263,654 | $253.6M | -46.0% | 4.82% | EC |
| 5 | Fidelity Revere Street Trust | 31635A303 | Feb 2026 | 176,471,877 | +40,255,289 | $176.5M | +29.6% | 3.35% | STIV |
| 6 | ALNYLAM PHARMACEUTICALS INC | 02043Q107 | Feb 2026 | 511,683 | +15,000 | $154.5M | -6.6% | 2.93% | EC |
| 7 | PRAXIS PRECISION MEDICINES INC. | 74006W207 | Feb 2026 | 371,429 | -19,071 | $130.0M | -1.1% | 2.47% | EC |
| 8 | INSMED INC | 457669307 | Feb 2026 | 1,109,201 | +298,100 | $118.6M | -2.1% | 2.25% | EC |
| 9 | ARGENX SE | 04016X101 | Feb 2026 | 141,444 | -7,900 | $118.2M | +3.2% | 2.25% | EC |
| 10 | ASCENDIS PHARMA A/S | N/A | Feb 2026 | 480,401 | +107,822 | $107.7M | +71111.4% | 2.04% | EC |
| 11 | REVOLUTION MEDICINES INC | 76155X100 | Feb 2026 | 675,072 | +236,300 | $106.3M | +137.5% | 2.02% | EC |
| 12 | UCB SA | N/A | Feb 2026 | 357,874 | NEW | $105.1M | — | 2.00% | EC |
| 13 | JAZZ PHARMACEUTICALS PLC | N/A | Feb 2026 | 410,452 | NEW | $97.1M | — | 1.84% | EC |
| 14 | SCHOLAR ROCK HOLDING CORP | 80706P103 | Feb 2026 | 1,650,449 | — | $81.4M | +11.4% | 1.55% | EC |
| 15 | NATERA INC | 632307104 | Feb 2026 | 331,532 | — | $74.1M | +7.4% | 1.41% | EC |
| 16 | MODERNA INC | 60770K107 | Feb 2026 | 1,432,529 | — | $67.6M | -11.9% | 1.28% | EC |
| 17 | AXSOME THERAPEUTICS INC | 05464T104 | Feb 2026 | 286,580 | +194,277 | $67.2M | +344.2% | 1.28% | EC |
| 18 | BIOGEN INC | 09062X103 | Feb 2026 | 338,835 | +39,400 | $66.4M | +15.6% | 1.26% | EC |
| 19 | PROTAGONIST THERAPEUTICS INC | 74366E102 | Feb 2026 | 607,713 | +101,000 | $60.5M | +29.7% | 1.15% | EC |
| 20 | ROIVANT SCIENCES LTD | N/A | Feb 2026 | 1,982,419 | NEW | $59.5M | — | 1.13% | EC |
| 21 | COGENT BIOSCIENCES INC | 19240Q201 | Feb 2026 | 1,604,794 | -86,600 | $56.1M | -14.6% | 1.07% | EC |
| 22 | TANGO THERAPEUTICS INC | 87583X109 | Feb 2026 | 2,339,362 | +1,753,362 | $51.4M | +687.7% | 0.98% | EC |
| 23 | CELCUITY INC | 15102K100 | May 2026 | 375,600 | NEW | $49.9M | — | 0.95% | EC |
| 24 | MADRIGAL PHARMACEUTICALS INC | 558868105 | Feb 2026 | 98,095 | +50,600 | $48.8M | +137.7% | 0.93% | EC |
| 25 | BRIDGEBIO PHARMA INC | 10806X102 | Feb 2026 | 707,304 | — | $46.9M | -0.3% | 0.89% | EC |
| 26 | IMMUNOME INC | 45257U108 | Feb 2026 | 2,131,664 | — | $46.5M | -0.1% | 0.88% | EC |
| 27 | UNITED THERAPEUTICS CORP DEL | 91307C102 | Feb 2026 | 82,591 | +37,998 | $46.0M | +104.7% | 0.87% | EC |
| 28 | KYMERA THERAPEUTICS INC | 501575104 | Feb 2026 | 556,441 | +94,000 | $45.3M | +7.2% | 0.86% | EC |
| 29 | ARRIVENT BIOPHARMA INC | 04272N102 | Feb 2026 | 1,439,803 | -240,200 | $43.6M | +12.9% | 0.83% | EC |
| 30 | CANDEL THERAPEUTICS INC | 137404109 | Feb 2026 | 4,864,753 | -1,047,198 | $40.4M | +30.1% | 0.77% | EC |
| 31 | STOKE THERAPEUTICS INC | 86150R107 | Feb 2026 | 1,293,694 | +501,100 | $40.0M | +38.6% | 0.76% | EC |
| 32 | DIANTHUS THERAPEUTICS INC | 252828108 | Feb 2026 | 420,518 | -11,700 | $39.1M | +64.0% | 0.74% | EC |
| 33 | TRAVERE THERAPEUTICS INC | 89422G107 | Feb 2026 | 798,843 | +78,500 | $37.7M | +75.6% | 0.72% | EC |
| 34 | IONIS PHARMACEUTICALS INC | 462222100 | Feb 2026 | 476,377 | — | $36.4M | -5.7% | 0.69% | EC |
| 35 | DYNE THERAPEUTICS INC | 26818M108 | Feb 2026 | 1,883,544 | +515,400 | $36.4M | +70.4% | 0.69% | EC |
| 36 | GALDERMA GROUP AG | N/A | Feb 2026 | 168,890 | NEW | $35.7M | — | 0.68% | EC |
| 37 | CORCEPT THERAPEUTICS INC | 218352102 | Feb 2026 | 506,746 | -68,900 | $35.2M | +71.4% | 0.67% | EC |
| 38 | CYTOKINETICS INC | 23282W605 | Feb 2026 | 449,175 | -54,000 | $34.5M | +10.1% | 0.65% | EC |
| 39 | ABIVAX SA | 00370M103 | Feb 2026 | 255,300 | -46,300 | $33.9M | -7.4% | 0.64% | EC |
| 40 | TREVI THERAPEUTICS INC | 89532M101 | Feb 2026 | 2,374,785 | +86,300 | $33.6M | +23.1% | 0.64% | EC |
| 41 | ORUKA THERAPEUTICS INC | 687604108 | Feb 2026 | 562,683 | +86,900 | $32.9M | +101.2% | 0.63% | EC |
| 42 | APOGEE THERAPEUTICS INC | 03770N101 | Feb 2026 | 398,657 | +5,900 | $32.7M | +19.1% | 0.62% | EC |
| 43 | ERASCA INC | 29479A108 | Feb 2026 | 2,533,680 | +2,493,800 | $32.5M | +5871.9% | 0.62% | EC |
| 44 | ARROWHEAD PHARMACEUTICALS INC | 04280A100 | Feb 2026 | 409,378 | — | $31.9M | +23.1% | 0.61% | EC |
| 45 | DISC MEDICINE INC | 254604101 | Feb 2026 | 454,774 | -77,400 | $31.6M | -10.8% | 0.60% | EC |
| 46 | CRINETICS PHARMACEUTICALS INC | 22663K107 | Feb 2026 | 886,871 | -39,800 | $31.5M | -17.2% | 0.60% | EC |
| 47 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | N/A | Feb 2026 | 637,600 | NEW | $30.8M | — | 0.59% | EC |
| 48 | NUVALENT INC | 670703107 | Feb 2026 | 273,399 | — | $30.2M | +8.3% | 0.57% | EC |
| 49 | SPYRE THERAPEUTICS INC | 00773J202 | Feb 2026 | 403,153 | +1,200 | $29.6M | +71.4% | 0.56% | EC |
| 50 | ANNEXON INC | 03589W102 | Feb 2026 | 5,082,296 | +348,700 | $27.5M | +3.9% | 0.52% | EC |
| 51 | INTELLIA THERAPEUTICS INC | 45826J105 | Feb 2026 | 1,914,833 | +307,000 | $26.9M | +21.6% | 0.51% | EC |
| 52 | VAXCYTE INC | 92243G108 | Feb 2026 | 474,755 | +4,300 | $24.4M | -16.0% | 0.46% | EC |
| 53 | EDGEWISE THERAPEUTICS INC | 28036F105 | Feb 2026 | 699,425 | -77,500 | $23.9M | +1.0% | 0.45% | EC |
| 54 | VIRIDIAN THERAPEUTICS INC | 92790C104 | Feb 2026 | 1,308,304 | +307,100 | $23.1M | -21.6% | 0.44% | EC |
| 55 | ARCUS BIOSCIENCES INC | 03969F109 | Feb 2026 | 852,700 | +21,600 | $21.6M | +27.6% | 0.41% | EC |
| 56 | BIO AB HOLDINGS LLC | N/A | Feb 2026 | 1,954,526 | NEW | $21.3M | — | 0.41% | EC |
| 57 | STRUCTURE THERAPEUTICS INC | 86366E106 | Feb 2026 | 542,038 | -22,400 | $21.3M | -40.0% | 0.40% | EC |
| 58 | VIATRIS INC | 92556V106 | May 2026 | 1,290,166 | NEW | $21.0M | — | 0.40% | EC |
| 59 | ALLOGENE THERAPEUTICS INC | 019770106 | Feb 2026 | 9,546,893 | +8,145,778 | $20.7M | +431.9% | 0.39% | EC |
| 60 | BICARA THERAPEUTICS INC | 055477103 | Feb 2026 | 944,900 | — | $20.6M | +29.6% | 0.39% | EC |
| 61 | MAZE THERAPEUTICS INC | 578784100 | Feb 2026 | 739,660 | +427,775 | $19.6M | +37.6% | 0.37% | EC |
| 62 | ZEALAND PHARMA A/S | N/A | Feb 2026 | 377,990 | NEW | $19.2M | — | 0.36% | EC |
| 63 | SOLID BIOSCIENCES INC | 83422E204 | Feb 2026 | 2,606,779 | +815,619 | $19.1M | +72.0% | 0.36% | EC |
| 64 | XENON PHARMACEUTICALS INC | 98420N105 | Feb 2026 | 345,564 | +48,200 | $18.9M | +47.1% | 0.36% | EC |
| 65 | IDEAYA BIOSCIENCES INC | 45166A102 | Feb 2026 | 637,957 | — | $18.8M | -8.5% | 0.36% | EC |
| 66 | SUMMIT THERAPEUTICS INC | 86627T108 | Feb 2026 | 1,067,669 | -21,500 | $18.7M | +3.6% | 0.36% | EC |
| 67 | VOR BIOPHARMA INC | 929033207 | Feb 2026 | 1,185,725 | -350,400 | $17.8M | -25.2% | 0.34% | EC |
| 68 | NEWAMSTERDAM PHARMA COMPANY NV | N/A | Feb 2026 | 523,700 | NEW | $17.6M | — | 0.33% | EC |
| 69 | MIRUM PHARMACEUTICALS INC | 604749101 | Feb 2026 | 170,600 | +150,200 | $17.3M | +819.7% | 0.33% | EC |
| 70 | RAPPORT THERAPEUTICS INC | 75383L102 | Feb 2026 | 428,273 | -43,500 | $16.9M | +23.5% | 0.32% | EC |
| 71 | TWIST BIOSCIENCE CORP | 90184D100 | Feb 2026 | 238,825 | +68,000 | $16.0M | +99.3% | 0.30% | EC |
| 72 | BIOHAVEN LTD | N/A | Feb 2026 | 1,448,896 | NEW | $16.0M | — | 0.30% | EC |
| 73 | AMYLYX PHARMACEUTICALS INC | 03237H101 | Feb 2026 | 1,097,175 | -122,400 | $15.7M | -14.9% | 0.30% | EC |
| 74 | MANNKIND CORP | 56400P706 | Feb 2026 | 4,078,401 | +1,893,300 | $15.4M | +114.5% | 0.29% | EC |
| 75 | KAILERA THERAPEUTICS INC | 482931102 | May 2026 | 619,399 | NEW | $14.2M | — | 0.27% | EC |
| 76 | RELAY THERAPEUTICS INC | 75943R102 | May 2026 | 1,010,467 | NEW | $14.2M | — | 0.27% | EC |
| 77 | UNIQURE N.V. | N/A | Feb 2026 | 473,082 | NEW | $13.5M | — | 0.26% | EC |
| 78 | ENLIVEN THERAPEUTICS INC | 29337E102 | Feb 2026 | 340,067 | -23,200 | $13.5M | +24.8% | 0.26% | EC |
| 79 | ALUMIS INC | 022307102 | Feb 2026 | 620,000 | +58,100 | $13.4M | -19.7% | 0.25% | EC |
| 80 | VIKING THERAPEUTICS INC | 92686J106 | Feb 2026 | 404,257 | — | $13.2M | -3.3% | 0.25% | EC |
| 81 | REPLIMUNE GROUP INC | 76029N106 | Feb 2026 | 1,514,745 | -349,800 | $13.2M | -7.7% | 0.25% | EC |
| 82 | TECTONIC THERAPEUTIC INC | 878972108 | Feb 2026 | 405,389 | -37,500 | $12.6M | +21.6% | 0.24% | EC |
| 83 | IDORSIA LTD | N/A | Feb 2026 | 2,174,283 | NEW | $12.4M | — | 0.24% | EC |
| 84 | MINERALYS THERAPEUTICS INC | 603170101 | Feb 2026 | 385,900 | -35,800 | $12.2M | -1.5% | 0.23% | EC |
| 85 | PTC THERAPEUTICS INC | 69366J200 | Feb 2026 | 160,411 | +25,900 | $11.8M | +29.2% | 0.22% | EC |
| 86 | DAMORA THERAPEUTICS INC | 36322Q206 | Feb 2026 | 454,559 | — | $11.3M | -15.9% | 0.21% | EC |
| 87 | TYRA BIOSCIENCES INC | 90240B106 | May 2026 | 337,000 | NEW | $11.3M | — | 0.21% | EC |
| 88 | HEMAB THERAPEUTICS HOLDINGS INC | 423494103 | May 2026 | 379,476 | NEW | $10.8M | — | 0.21% | EC |
| 89 | FORTE BIOSCIENCES INC | 34962G208 | Feb 2026 | 563,591 | +252,626 | $10.7M | +14.4% | 0.20% | EC |
| 90 | EIKON THERAPEUTICS INC | 282564103 | Feb 2026 | 974,333 | +669,245 | $10.6M | +151.2% | 0.20% | EC |
| 91 | ABSCI CORP | 00091E109 | Feb 2026 | 1,540,796 | — | $10.4M | +146.4% | 0.20% | EC |
| 92 | CAPRICOR THERAPEUTICS INC | 14070B309 | Feb 2026 | 334,200 | +19,500 | $10.0M | +13.9% | 0.19% | EC |
| 93 | CITY THERAPEUTICS INC | N/A | Feb 2026 | 684,300 | NEW | $10.0M | — | 0.19% | EP |
| 94 | CYTOMX THERAPEUTICS INC | 23284F105 | Feb 2026 | 2,774,340 | +1,551,800 | $10.0M | +52.1% | 0.19% | EC |
| 95 | GUBRA A/S | N/A | Feb 2026 | 166,002 | NEW | $9.3M | — | 0.18% | EC |
| 96 | IMMUNOVANT INC | 45258J102 | Feb 2026 | 272,221 | +22,200 | $9.1M | +30.7% | 0.17% | EC |
| 97 | RHYTHM PHARMACEUTICALS INC | 76243J105 | Feb 2026 | 99,803 | — | $8.8M | -4.8% | 0.17% | EC |
| 98 | TRIVENI BIO INC | N/A | Feb 2026 | 7,167,431 | NEW | $8.7M | — | 0.17% | EP |
| 99 | BIO AB HOLDINGS LLC | N/A | Feb 2026 | 1,954,526 | NEW | $8.7M | — | 0.17% | EC |
| 100 | VTV THERAPEUTICS INC | 918385204 | Feb 2026 | 260,391 | — | $8.7M | -12.6% | 0.16% | EC |
| 101 | BEONE MEDICINES LTD | 07725L102 | Feb 2026 | 29,698 | -12,000 | $8.6M | -35.3% | 0.16% | EC |
| 102 | NUVATION BIO INC | 67080N101 | Feb 2026 | 1,758,533 | -406,400 | $8.4M | -34.3% | 0.16% | EC |
| 103 | HANSA BIOPHARMA AB | N/A | Feb 2026 | 2,290,077 | NEW | $8.4M | — | 0.16% | EC |
| 104 | IMMUNOCORE HOLDINGS PLC | 45258D105 | Feb 2026 | 287,200 | -34,300 | $8.3M | -20.1% | 0.16% | EC |
| 105 | OLEMA PHARMACEUTICALS INC | 68062P106 | Feb 2026 | 628,100 | -65,000 | $8.3M | -50.6% | 0.16% | EC |
| 106 | Fidelity Revere Street Trust | 31635A105 | Feb 2026 | 8,221,532 | +3,354,811 | $8.2M | +68.9% | 0.16% | STIV |
| 107 | BEAM THERAPEUTICS INC | 07373V105 | Feb 2026 | 244,914 | — | $8.1M | +15.7% | 0.15% | EC |
| 108 | CG ONCOLOGY INC | 156944100 | Feb 2026 | 128,728 | +106,100 | $8.0M | +502.7% | 0.15% | EC |
| 109 | SENSORION SA | N/A | Feb 2026 | 17,132,230 | NEW | $8.0M | — | 0.15% | EC |
| 110 | OCULAR THERAPEUTIX INC | 67576A100 | Feb 2026 | 784,000 | — | $7.1M | +0.8% | 0.13% | EC |
| 111 | ZENAS BIOPHARMA INC | 98937L105 | Feb 2026 | 380,400 | — | $7.0M | -30.2% | 0.13% | EC |
| 112 | GERON CORP | 374163103 | Feb 2026 | 5,452,212 | -1,040,300 | $6.8M | -37.5% | 0.13% | EC |
| 113 | JADE BIOSCIENCES INC | 008064206 | Feb 2026 | 321,707 | — | $6.8M | +41.9% | 0.13% | EC |
| 114 | IMMUNEERING CORP | 45254E107 | Feb 2026 | 1,095,798 | -194,900 | $6.3M | -1.8% | 0.12% | EC |
| 115 | BIONTECH SE | 09075V102 | Feb 2026 | 64,900 | -20,500 | $6.2M | -33.8% | 0.12% | EC |
| 116 | CANDID THERAPEUTICS | N/A | Feb 2026 | 1,666,667 | NEW | $6.2M | — | 0.12% | EP |
| 117 | X4 PHARMACEUTICALS INC | 98420X202 | Feb 2026 | 1,428,500 | -257,200 | $6.2M | +6.2% | 0.12% | EC |
| 118 | NURIX THERAPEUTICS INC | 67080M103 | Feb 2026 | 333,346 | -63,300 | $5.9M | -6.5% | 0.11% | EC |
| 119 | AKTIS ONCOLOGY INC | 01021M104 | Feb 2026 | 283,355 | -100,600 | $5.9M | -24.0% | 0.11% | EC |
| 120 | CAMP4 THERAPEUTICS CORP | 13463J101 | Feb 2026 | 1,326,208 | — | $5.8M | -2.2% | 0.11% | EC |
| 121 | ODYSSEY THERAPEUTICS INC | 67613T104 | May 2026 | 339,500 | NEW | $5.8M | — | 0.11% | EC |
| 122 | CARDURION PHARMACEUTICALS INC | N/A | Feb 2026 | 1,020,908 | NEW | $5.6M | — | 0.11% | EP |
| 123 | DESIGN THERAPEUTICS INC | 25056L103 | Feb 2026 | 534,931 | -81,900 | $5.6M | -12.9% | 0.11% | EC |
| 124 | TG THERAPEUTICS INC | 88322Q108 | Feb 2026 | 146,231 | +80,000 | $5.5M | +178.4% | 0.11% | EC |
| 125 | TAYSHA GENE THERAPIES INC | 877619106 | Feb 2026 | 940,476 | — | $5.5M | +29.6% | 0.10% | EC |
| 126 | CAMP4 THERAPEUTICS CORP | N/A | Feb 2026 | 1,226,606 | NEW | $5.4M | — | 0.10% | EC |
| 127 | LB PHARMACEUTICALS INC | 50180M108 | Feb 2026 | 187,731 | -34,000 | $5.3M | -1.4% | 0.10% | EC |
| 128 | PROTHENA CORP PLC | N/A | Feb 2026 | 495,517 | NEW | $5.0M | — | 0.10% | EC |
| 129 | ZENAS BIOPHARMA INC | N/A | Feb 2026 | 263,137 | NEW | $4.8M | — | 0.09% | EC |
| 130 | NEURONA THERAPEUTICS INC | N/A | Feb 2026 | 1,618,100 | NEW | $4.7M | — | 0.09% | EP |
| 131 | PHARVARIS BV | N/A | Feb 2026 | 147,914 | NEW | $4.5M | — | 0.08% | EC |
| 132 | DENALI THERAPEUTICS INC | 24823R105 | Feb 2026 | 205,263 | — | $4.3M | -0.7% | 0.08% | EC |
| 133 | SCORPION THERAPEUTICS INC | N/A | Feb 2026 | 5,166,448 | NEW | $4.3M | — | 0.08% | EC |
| 134 | SANA BIOTECHNOLOGY INC | 799566104 | Feb 2026 | 1,263,152 | — | $4.2M | -21.6% | 0.08% | EC |
| 135 | VERA THERAPEUTICS INC | 92337R101 | Feb 2026 | 109,013 | — | $3.9M | -12.9% | 0.07% | EC |
| 136 | SIONNA THERAPEUTICS INC | 829401108 | May 2026 | 80,900 | NEW | $3.5M | — | 0.07% | EC |
| 137 | PARABILIS MEDICINES INC | N/A | Feb 2026 | 491,600 | NEW | $3.4M | — | 0.06% | EP |
| 138 | CRESCENT BIOPHARMA INC | N/A | Feb 2026 | 149,142 | NEW | $3.1M | — | 0.06% | EC |
| 139 | ARS PHARMACEUTICALS INC | 82835W108 | Feb 2026 | 335,156 | — | $3.0M | -2.3% | 0.06% | EC |
| 140 | JANUX THERAPEUTICS INC | 47103J105 | Feb 2026 | 206,670 | — | $3.0M | +7.2% | 0.06% | EC |
| 141 | TRIVENI BIO INC | N/A | Feb 2026 | 2,388,534 | NEW | $3.0M | — | 0.06% | EP |
| 142 | ALECTOR INC | 014442107 | Feb 2026 | 1,380,204 | -840,900 | $3.0M | -44.8% | 0.06% | EC |
| 143 | CARTESIAN THERAPEUTICS INC | 816212302 | Feb 2026 | 366,554 | — | $2.8M | -0.7% | 0.05% | EC |
| 144 | MOONLAKE IMMUNOTHERAPEUTICS | 61559X104 | Feb 2026 | 143,558 | — | $2.8M | +9.5% | 0.05% | EC |
| 145 | NATIONAL RESILIENCE INC | N/A | Feb 2026 | 732,064 | NEW | $2.5M | — | 0.05% | EP |
| 146 | CRESCENT BIOPHARMA INC | N/A | Feb 2026 | 113,421 | NEW | $2.3M | — | 0.04% | EC |
| 147 | SHATTUCK LABS INC | 82024L103 | Feb 2026 | 391,662 | — | $2.3M | +51.8% | 0.04% | EC |
| 148 | MBX BIOSCIENCES INC | 55287L101 | May 2026 | 73,100 | NEW | $2.3M | — | 0.04% | EC |
| 149 | VERTEX PHARMACEUTICALS INC | 92532F100 | Feb 2026 | 5,106 | -107,794 | $2.3M | -95.9% | 0.04% | EC |
| 150 | WAVE LIFE SCIENCES LTD | N/A | Feb 2026 | 344,940 | NEW | $2.3M | — | 0.04% | EC |
| 151 | GH RESEARCH PLC | N/A | Feb 2026 | 92,500 | NEW | $2.2M | — | 0.04% | EC |
| 152 | ZURA BIO LTD | N/A | Feb 2026 | 509,657 | NEW | $2.2M | — | 0.04% | EC |
| 153 | BRIDGEBIO ONCOLOGY THERAPEUTIC | 107924102 | Feb 2026 | 240,300 | — | $2.2M | -10.6% | 0.04% | EC |
| 154 | VERADERMICS INC | 922967104 | Feb 2026 | 20,800 | — | $2.1M | +120.1% | 0.04% | EC |
| 155 | KARDIGAN INC | N/A | Feb 2026 | 93,611 | NEW | $2.0M | — | 0.04% | EP |
| 156 | CELLCENTRIC LTD | N/A | Feb 2026 | 417,101 | NEW | $2.0M | — | 0.04% | EP |
| 157 | PALVELLA THERAPEUTICS INC | 697947109 | Feb 2026 | 16,700 | — | $2.0M | -12.3% | 0.04% | EC |
| 158 | UPSTREAM BIO INC | 91678A107 | Feb 2026 | 234,657 | — | $2.0M | +8.9% | 0.04% | EC |
| 159 | CARTESIAN THERAPEUTICS INC | 816212112 | Feb 2026 | 5,385,728 | — | $1.6M | +0.0% | 0.03% | EC |
| 160 | FOGHORN THERAPEUTICS INC | 344174107 | Feb 2026 | 351,578 | -302,700 | $1.5M | -59.5% | 0.03% | EC |
| 161 | NEUROGENE INC | 64135M105 | Feb 2026 | 51,100 | — | $1.4M | +20.6% | 0.03% | EC |
| 162 | ATEA PHARMACEUTICALS INC | 04683R106 | Feb 2026 | 287,662 | +50,128 | $1.3M | +20.8% | 0.03% | EC |
| 163 | ANAPTYSBIO INC | 032724106 | Feb 2026 | 23,300 | — | $1.3M | +1.1% | 0.02% | EC |
| 164 | ZYMEWORKS DELAWARE INC | 98985Y108 | May 2026 | 47,873 | NEW | $1.2M | — | 0.02% | EC |
| 165 | LEXICON PHARMACEUTICALS INC | 528872302 | Feb 2026 | 515,300 | — | $1.1M | +48.3% | 0.02% | EC |
| 166 | PERSPECTIVE THERAPEUTICS INC | 46489V302 | Feb 2026 | 258,600 | — | $1.0M | -27.0% | 0.02% | EC |
| 167 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $982K | — | 0.02% | EC |
| 168 | ATYR PHARMA INC | 002120202 | Feb 2026 | 1,754,594 | — | $952K | -43.5% | 0.02% | EC |
| 169 | LEGEND BIOTECH CORP | 52490G102 | Feb 2026 | 32,710 | — | $888K | +42.9% | 0.02% | EC |
| 170 | TARSUS PHARMACEUTICALS INC | 87650L103 | Feb 2026 | 11,500 | +6,700 | $683K | +88.4% | 0.01% | EC |
| 171 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $647K | — | 0.01% | EC |
| 172 | CYCLERION THERAPEUTICS INC | N/A | Feb 2026 | 246,900 | NEW | $630K | — | 0.01% | EC |
| 173 | BIOMEA FUSION INC | 09077A106 | Feb 2026 | 452,663 | — | $625K | +0.7% | 0.01% | EC |
| 174 | REGENERON PHARMACEUTICALS INC | 75886F107 | Feb 2026 | 1,000 | -100,316 | $615K | -99.2% | 0.01% | EC |
| 175 | SEPTERNA INC | 81734D104 | May 2026 | 19,400 | NEW | $586K | — | 0.01% | EC |
| 176 | HARMONY BIOSCIENCES HOLDINGS INC | 413197104 | Feb 2026 | 17,525 | — | $554K | +10.7% | 0.01% | EC |
| 177 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $512K | — | 0.01% | EC |
| 178 | BELITE BIO INC | 07782B104 | May 2026 | 3,100 | NEW | $447K | — | 0.01% | EC |
| 179 | INMED PHARMACEUTICALS INC | N/A | Feb 2026 | 191,200 | NEW | $442K | — | 0.01% | EC |
| 180 | KORRO BIO INC | N/A | Feb 2026 | 32,866 | NEW | $441K | — | 0.01% | EC |
| 181 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $440K | — | 0.01% | EC |
| 182 | AVALYN PHARMA INC | 05348Y105 | May 2026 | 15,000 | NEW | $432K | — | 0.01% | EC |
| 183 | ELEVATEBIO, LLC | N/A | Feb 2026 | 216,600 | NEW | $399K | — | 0.01% | EP |
| 184 | FIRST TRACKS BIOTHERAPEUTICS INC | 337185102 | May 2026 | 23,300 | NEW | $372K | — | 0.01% | EC |
| 185 | BIOCRYST PHARMACEUTICALS INC | 09058V103 | Feb 2026 | 37,881 | — | $338K | +1.8% | 0.01% | EC |
| 186 | ANTARES THERAPEUTICS INC | N/A | Feb 2026 | 325,500 | NEW | $296K | — | 0.01% | EC |
| 187 | LENZ THERAPEUTICS INC | 52635N103 | Feb 2026 | 38,058 | — | $296K | -42.3% | 0.01% | EC |
| 188 | GENERATE BIOMEDICINE INC | 370920100 | May 2026 | 21,800 | NEW | $286K | — | 0.01% | EC |
| 189 | KEROS THERAPEUTICS INC | 492327101 | Feb 2026 | 24,578 | — | $277K | -20.7% | 0.01% | EC |
| 190 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $270K | — | 0.01% | EC |
| 191 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $263K | — | 0.01% | EC |
| 192 | SEAPORT THERAPEUTICS INC | 81221K108 | May 2026 | 12,700 | NEW | $231K | — | 0.00% | EC |
| 193 | NOVOCURE LTD | N/A | Feb 2026 | 11,113 | NEW | $189K | — | 0.00% | EC |
| 194 | BIOXCEL THERAPEUTICS INC | 09075P204 | Feb 2026 | 90,300 | — | $106K | -29.9% | 0.00% | EC |
| 195 | BLUE MARLIN THERAPEUTICS, INC. | N/A | Feb 2026 | 1,636 | NEW | $102K | — | 0.00% | EC |
| 196 | INHIBIKASE THERAPEUTICS INC | 45719W205 | Feb 2026 | 56,270 | — | $98K | -14.6% | 0.00% | EC |
| 197 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $86K | — | 0.00% | EC |
| 198 | ULTRAGENYX PHARMACEUTICAL INC | 90400D108 | Feb 2026 | 3,489 | — | $84K | +2.4% | 0.00% | EC |
| 199 | FOGHORN THERAPEUTICS INC | N/A | Feb 2026 | 372,579 | NEW | $73K | — | 0.00% | EC |
| 200 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $43K | — | 0.00% | EC |
| 201 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $43K | — | 0.00% | EC |
| 202 | MYOS CORP | N/A | Feb 2026 | 33,334 | NEW | $42K | — | 0.00% | EC |
| 203 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $32K | — | 0.00% | EC |
| 204 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $20K | — | 0.00% | EC |
| 205 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $19K | — | 0.00% | EC |
| 206 | CYCLERION THERAPEUTICS INC | N/A | Feb 2026 | 4,740 | NEW | $15K | — | 0.00% | EC |
| 207 | FOGHORN THERAPEUTICS INC | N/A | Feb 2026 | 372,579 | NEW | $4K | — | 0.00% | EC |
| 208 | BIOMEA FUSION INC | N/A | Feb 2026 | 46,134 | NEW | $857 | — | 0.00% | EC |
| 209 | TUBULIS GMBH | N/A | Feb 2026 | 9,200 | NEW | $184 | — | 0.00% | EC |
| 210 | AFFERENT PHARMA | N/A | Feb 2026 | 8,274,568 | NEW | $83 | — | 0.00% | EP |
| 211 | SCORPION THERAPEUTICS INC | N/A | Feb 2026 | 5,166,448 | NEW | $52 | — | 0.00% | EC |
| 212 | CHINOOK THERAPEUTICS INC | N/A | Feb 2026 | 115,821 | NEW | $1 | — | 0.00% | EC |
| 213 | OPTINOSE INC | 68404V118 | Feb 2026 | 91,712 | — | $1 | +0.0% | 0.00% | EC |
| 214 | AXCELLA HEALTH INC | 05454B204 | Feb 2026 | 66,454 | — | $1 | +0.0% | 0.00% | EC |
| 215 | MEDAVAIL HOLDINGS INC | N/A | Feb 2026 | 55 | NEW | $0 | — | 0.00% | EC |
| ✕ | ASCENDIS PHARMA A/S | 04351P101 | — | 558,201 | SOLD | $130.3M | — | — | — |
| ✕ | CENTESSA PHARMACEUTICALS PLC | 152309100 | — | 2,187,494 | SOLD | $58.8M | — | — | — |
| ✕ | TERNS PHARMACEUTICALS INC | 880881107 | — | 1,079,186 | SOLD | $45.5M | — | — | — |
| ✕ | SOLENO THERAPEUTICS INC | 834203309 | — | 87,300 | SOLD | $3.4M | — | — | — |
| ✕ | ENGENE HOLDINGS INC | 29286M105 | — | 232,200 | SOLD | $2.3M | — | — | — |
| ✕ | EXELIXIS INC | 30161Q104 | — | 40,610 | SOLD | $1.8M | — | — | — |
| ✕ | DAY ONE BIOPHARMACEUTICALS INC | 23954D109 | — | 108,347 | SOLD | $1.1M | — | — | — |
| ✕ | APELLIS PHARMACEUTICALS INC | 03753U106 | — | 23,822 | SOLD | $0.5M | — | — | — |
| ✕ | ENTRADA THERAPEUTICS INC | 29384C108 | — | 14,169 | SOLD | $0.2M | — | — | — |